![Göran Forsberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Göran Forsberg
Plus aucun poste en cours
Profil
Göran Forsberg is the founder of Trainparts Sweden AB, founded in 2014.
Current jobs include Director at Mesenkia Therapeutics AB starting in 2025 and Independent Non-Executive Director at Disruptive Pharma AB starting in 2026.
Former jobs include Chief Executive Officer at Cantargia AB from 2014 to 2025, Non-Executive Director at Isogenica Ltd., Director at Active Security Trading AB, Director at Active Biotech Research AB, Director at Actinova AB, Independent Director at Guard Therapeutics International AB, Head-Business Development & Investor Relation at the University of Adelaide, Head-Business Development & Investor Relation at Kabigen AB, and Chief Business Officer & VP-Investor Relations at Active Biotech AB from 2011 to 2014.
Postes actifs de Göran Forsberg
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Göran Forsberg
| Sociétés | Poste | Fin |
|---|---|---|
| CANTARGIA AB | Directeur Général | 05/02/2025 |
| ACTIVE BIOTECH AB | Investor Relations Contact | 01/08/2014 |
Trainparts Sweden AB
 Trainparts Sweden AB Metal FabricationProducer Manufacturing Engages in maintain, rebuild and remanufacture leaf springs, buffers and traction devices for railway vehicles | Fondateur | - |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Investor Relations Contact | - |
Kabigen AB | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
University of Adelaide
University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Commercial Services |
Kabigen AB | |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Guard Therapeutics International AB
 Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
Active Security Trading AB | |
Active Biotech Research AB
 Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Actinova AB | |
Trainparts Sweden AB
Trainparts Sweden AB Metal FabricationProducer Manufacturing Engages in maintain, rebuild and remanufacture leaf springs, buffers and traction devices for railway vehicles | Producer Manufacturing |
